HETLIOZ (TASIMELTEON) CAPSULES Trademark

Trademark Overview


On Monday, April 11, 2022, a trademark application was filed for HETLIOZ (TASIMELTEON) CAPSULES with the United States Patent and Trademark Office. The USPTO has given the HETLIOZ (TASIMELTEON) CAPSULES trademark a serial number of 97357860. The federal status of this trademark filing is THIRD EXTENSION - GRANTED as of Friday, January 3, 2025. This trademark is owned by Vanda Pharmaceuticals Inc.. The HETLIOZ (TASIMELTEON) CAPSULES trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations containing tasimelteon for use in the treatment of Autism Spectrum Disorder; Pharmaceutical preparations containing tasimelteon for use in the treatment of Delayed Sleep Phase Disorder; Pharmaceutical preparations containing tasimelteon for use in the treatment of Jet Lag Disorder; Pharmaceutical preparations containing tasimelteon for use in the treatment of depression; Pharmaceutical preparations containing tasimelteon for use in the treatment of Major Depressive Disorder
hetlioz (tasimelteon) capsules

General Information


Serial Number97357860
Word MarkHETLIOZ (TASIMELTEON) CAPSULES
Filing DateMonday, April 11, 2022
Status732 - THIRD EXTENSION - GRANTED
Status DateFriday, January 3, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, August 29, 2023

Trademark Statements


Description of MarkThe mark consists of the word "HETLIOZ" on a first line, and "(TASIMELTEON) CAPSULES" on a second line, with an arc of eleven solid circles of increasing size connecting the first and second lines of text.
Goods and ServicesPharmaceutical preparations containing tasimelteon for use in the treatment of Autism Spectrum Disorder; Pharmaceutical preparations containing tasimelteon for use in the treatment of Delayed Sleep Phase Disorder; Pharmaceutical preparations containing tasimelteon for use in the treatment of Jet Lag Disorder; Pharmaceutical preparations containing tasimelteon for use in the treatment of depression; Pharmaceutical preparations containing tasimelteon for use in the treatment of Major Depressive Disorder
NOT AVAILABLE"TASIMELTEON CAPSULES"

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, April 18, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameVanda Pharmaceuticals Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWashington, DC 20037

Party NameVanda Pharmaceuticals Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWashington, DC 20037

Trademark Events


Event DateEvent Description
Thursday, February 9, 2023EXAMINERS AMENDMENT -WRITTEN
Thursday, April 14, 2022NEW APPLICATION ENTERED
Monday, April 18, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, April 19, 2022NOTICE OF DESIGN SEARCH CODE E-MAILED
Monday, January 23, 2023ASSIGNED TO EXAMINER
Thursday, February 9, 2023EXAMINERS AMENDMENT E-MAILED
Thursday, February 9, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, February 9, 2023EXAMINER'S AMENDMENT ENTERED
Tuesday, March 14, 2023NON-FINAL ACTION WRITTEN
Tuesday, March 14, 2023NON-FINAL ACTION E-MAILED
Tuesday, March 14, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, May 4, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, May 4, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, May 4, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, July 19, 2023ASSIGNED TO EXAMINER
Wednesday, July 26, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 9, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 29, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 29, 2023PUBLISHED FOR OPPOSITION
Tuesday, October 24, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, March 29, 2024SOU TEAS EXTENSION RECEIVED
Friday, March 29, 2024SOU EXTENSION 1 FILED
Friday, March 29, 2024SOU EXTENSION 1 GRANTED
Saturday, March 30, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 1, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, October 1, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 1, 2024SOU EXTENSION 2 FILED
Tuesday, October 1, 2024SOU EXTENSION 2 GRANTED
Thursday, January 2, 2025SOU TEAS EXTENSION RECEIVED
Friday, January 3, 2025SOU EXTENSION 3 FILED
Friday, January 3, 2025SOU EXTENSION 3 GRANTED
Monday, March 3, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED